Links to all abstracts Hammersmith 2010. |
Click here for details of Endocrine Symposium http://metmed.info
Oral Presentations
OC1 Limitations of functional imaging in a patient with phaeochromocytoma
OC2 Rare phaeo-type in an odd phenotype
OC3 Difficulties in Management of Hypercortisolism
OC4 A Case of Primary Hyperaldosteronism with Discordant Imaging and Adrenal Vein Sampling Results
OC5 Thionamide induced agranulocytosis in a patient with Graves’ thyrotoxicosis.
OC6 Should thyroid surgery be the treatment of choice for thyrotoxic parents with young children?
Q001 The multidisciplinary approach for re-operative parathyroidectomy
Q002 Severe hypercalcaemia associated with Graves' disease
Q003 Graves’ disease following several years of Primary Hypothyroidism
Q004 The Importance of the Multidisciplinary Input in the management of Primary Hyperparathyroidism
Q005 A case of neuropsychiatric symptoms and recurrent thyrotoxicosis: Thyroid storm or encephalopathy associated with autoimmune thyroid disease?
Q006 Preliminary report of the use of Everolimus in a patient with progressive medullary thyroid carcinoma
Q007 “ UTERINE NEUROENDOCRINE TUMOUR –AN UNUSUAL CAUSE OF HYPONATRAEMIA” AND THE ROLE OF TOLVAPTAN, A VASOPRESSIN V2 RECEPTOR ANTAGONIST
Q008 Limitations of functional imaging in a patient with phaeochromocytoma
Q009 A case of metastatic neuroendocrine tumour illustrating that a conservative approach to the management of such tumours can be justified
Q010 Rare phaeo-type in an odd phenotype
Q011 Establishing the diagnosis in a curious case of primary hyperparathyroidism
Q012 Paraganglioma: Gallium-68 DOTOTATE PET CT scan superior to MIBG scanning in metastatic disease
Q013 Iatrogenic Cushing’s Syndrome Caused by Interaction of Antiretroviral Drugs and Inhaled Steroids.
Q014 Management of a patient with an intra-partum pituitary haemorrhage
Q015 Thionamide induced agranulocytosis in a patient with Graves’ thyrotoxicosis.
Q016 Human chorionic gonadotrophin induced gestational thyrotoxicosis: 2 case reports and a discussion.
Q017 Audit of local management of hyperparathyroidism and evaluation of vitamin D deficiency in PHPT
Q018 Should thyroid surgery be the treatment of choice for thyrotoxic parents with young children?
Q019 Undiagnosed Acromegaly in a Hyperthyroid Diabetic
Q020 The Most Overactive Thyroid Ever?
Q021 The predictive value of GH and IGF-1 burdens for ischaemic heart disease and cardiomyopathy in patients with treated acromegaly.
Q022 Type 2 diabetes and impaired glucose tolerance are associated with increased overall GH exposure in treated acromegalic patients
Q023 Metastatic Somatostatinoma: A rare cause of diabetes requiring insulin therapy
Q024 Hypogonadotrophic hypogonadism in the setting of secondary haemochromatosis
Q025 Adrenal incidentalomas: single centre review of hormonal and imaging results in 125 individuals.
Q026 An unusual cause of acute adrenal insufficiency
Q027 An important treatable differential for anaplastic thyroid carcinoma.
Q028 Identifying patients with Familial Hypercholesterolaemia and evaluating management.
Q029 Non-functioning pituitary adenoma: an incidental finding or a stroke mimic?
Q030 A difference of opinion – poor concordance between clinical, biochemical and radiographic findings in a case of an adrenal incidentaloma
Q031 Occult Thyroid Papillary Carcinoma Found Incidentally in the Cervical Lymph Nodes
Q032 Thyrotoxicosis associated with a molar pregnancy and hyperemesis gravidarum
Q033 Sub-total Retroperitoneoscopic Adrenalectomy for a Conn’s Adenoma
Q034 Difficulties in Management of Hypercortisolism
Q035 The Role of Adrenal Vein Sampling (AVS) in the Diagnosis and Management of Primary Hyperaldosteronism – The Hammersmith Experience
Q036 Serum 25-hydroxyvitamin D concentrations are lower in women with Gestational Diabetes Mellitus
Q037 A Case of Primary Hyperaldosteronism with Discordant Imaging and Adrenal Vein Sampling Results